Evaluation of Cross-Linked Polyelectrolyte (CLP) With Placebo in Heart Failure Subjects
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 270 participants.
Also called NCT01736735
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 270 participants
- Sponsor
- Sorbent Therapeutics
- Registry
-
NCT01736735
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Argentina, Israel
- Registry status
- Unknown status
Technical summary
Registry record NCT01736735. Randomized; double masking; primary purpose treatment. Start 2013-01 (registry gives no type); primary completion 2014-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of Cross-Linked Polyelectrolyte (CLP) With Placebo in Heart Failure Subjects
- Acronym
- STEPWISE
- Condition
- Heart Failure
- Intervention (Drug)
- CLP
- Intervention (Drug)
- placebo
- Lead sponsor
- Sorbent Therapeutics
Record details
- Record id
cardio:ct-nct01736735- Content hash
7c0c8c7ca8527a26846725daa7f0c2b39a3092367833014de77465377dda9fa3